المؤلفون: Diallo, Alhassane¹ (AUTHOR) alhassane.diallo@umontpellier.fr, Carlos‐Bolumbu, Miguel² (AUTHOR), Galtier, Florence³ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. Jan2024, Vol. 26 Issue 1, p392-395. 4p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure, *ASYMMETRIC dimethylarginine, *GLUCOSE, *MORTALITY, *HOSPITAL care, CARDIOVASCULAR disease related mortality

المؤلفون: Klen, Jasna^1,2 (AUTHOR) jasna.klen@gmail.com, Dolžan, Vita³ (AUTHOR) vita.dolzan@mf.uni-lj.si

المصدر: Pharmaceutics. Jul2023, Vol. 15 Issue 7, p1995. 20p.

مصطلحات موضوعية: *DIABETIC nephropathies, *SODIUM-glucose cotransporter 2 inhibitors, *CREATININE, *TYPE 2 diabetes, *RENAL replacement therapy, *GLUCOSE

المؤلفون: Yao, Xueting^1,2 (AUTHOR), Zhou, Jiawei³ (AUTHOR), Song, Ling^1,2 (AUTHOR), Ren, Yupeng⁴ (AUTHOR) renyupeng.pk@gmail.com, Hu, Pei⁵ (AUTHOR) hubei01_pumch@163.com, Liu, Dongyang^1,2 (AUTHOR) liudongyang@vip.sina.com

المصدر: CPT: Pharmacometrics & Systems Pharmacology. Apr2023, Vol. 12 Issue 4, p487-499. 13p.

مصطلحات موضوعية: *SODIUM-glucose cotransporters, *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 2 diabetes, *BLOOD sugar, *PLACEBOS, *GLUCOSE

المؤلفون: Zügner, Elmar¹ (AUTHOR) elmar.zuegner@joanneum.at, Yang, Hsiu-Chiung² (AUTHOR) ginnie.yang@bayer.com, Kotzbeck, Petra^3,4,5 (AUTHOR) petra.kotzbeck@joanneum.at, Boulgaropoulos, Beate^1,3 (AUTHOR) beate.boulgaropoulos@joanneum.at, Sourij, Harald³ (AUTHOR), Hagvall, Sepideh² (AUTHOR) sepideh.hagvall@astrazeneca.com, Elmore, Charles S.⁶ (AUTHOR) chad.elmore@astrazeneca.com, Esterline, Russell⁷ (AUTHOR) russell.esterline@astrazeneca.com, Moosmang, Sven² (AUTHOR) sven.moosmang@astrazeneca.com, Oscarsson, Jan⁷ (AUTHOR) jan.oscarsson@astrazeneca.com, Pieber, Thomas R.^1,3 (AUTHOR) thomas.pieber@joanneum.at, Peng, Xiao-Rong² (AUTHOR) xiao-rong.peng@astrazeneca.com, Magnes, Christoph¹ (AUTHOR) xiao-rong.peng@astrazeneca.com

المصدر: International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 14, p7966-7966. 17p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *CELL metabolism, *OXIDATIVE phosphorylation, *MITOCHONDRIA, *GLYCOLYSIS, *GLUCOSE

المؤلفون: Shao, Hui^1,2 hui.shao@cop.ufl.edu, Laxy, Michael^1,3, Benoit, Stephen R.¹, Cheng, Yiling J.¹, Gregg, Edward W.^1,4, Zhang, Ping¹

المصدر: Diabetes Care. Apr2021, Vol. 44 Issue 4, p925-934. 10p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *GLUCAGON-like peptide 1, *HEALTH insurance, *PEPTIDE receptors, *TYPE 2 diabetes, *MEDICAL care costs, *DRUGS, *GLUCOSE

المؤلفون: Chiba, Koki¹ (AUTHOR), Nomoto, Hiroshi¹ (AUTHOR), Nakamura, Akinobu¹ (AUTHOR), Cho, Kyu Yong^1,2 (AUTHOR), Yamashita, Kumiko³ (AUTHOR), Shibayama, Yui¹ (AUTHOR), Miya, Aika¹ (AUTHOR), Kameda, Hiraku¹ (AUTHOR), Kurihara, Yoshio³ (AUTHOR), Aoki, Shin⁴ (AUTHOR), Atsumi, Tatsuya¹ (AUTHOR), Miyoshi, Hideaki^1,5 (AUTHOR) hmiyoshi@med.hokudai.ac.jp

المصدر: Journal of Diabetes Investigation. Feb2021, Vol. 12 Issue 2, p176-183. 8p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 1 diabetes, *GLUCOSE, *GLYCOSYLATED hemoglobin, *DRUG efficacy

المؤلفون: Selvaraj, Senthil¹ (AUTHOR), Kelly, Daniel P.² (AUTHOR), Margulies, Kenneth B.^1,2,3 (AUTHOR)

المصدر: Circulation. 6/2/2020, Vol. 141 Issue 22, p1800-1812. 13p.

مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *HEART failure, *ACETONEMIA, *KETONES, *FATTY acid oxidation, *GLUCOSE metabolism, *ENERGY metabolism, *LIVER, *MYOCARDIAL reperfusion complications, *CARDIAC output, *STROKE volume (Cardiac output), *ACIDOSIS, *HEART diseases, *MICE, *ANIMALS, *CARDIOTONIC agents, *FATTY acids, *DISEASE complications

المؤلفون: Yaribeygi, Habib¹ (AUTHOR), Hemmati, Mohammad Amin² (AUTHOR), Nasimi, Fatemeh¹ (AUTHOR), Maleki, Mina³ (AUTHOR), Jamialahmadi, Tannaz⁴ (AUTHOR), Reiner, Ivan⁵ (AUTHOR), Reiner, Željko^6,7 (AUTHOR) zreiner@kbc-zagreb.hr, Sahebkar, Amirhossein^4,8,9 (AUTHOR)

المصدر: Journal of Clinical Medicine. Jun2023, Vol. 12 Issue 11, p3815. 12p.

مصطلحات موضوعية: *EMPAGLIFLOZIN, *KIDNEY physiology, *SODIUM-glucose cotransporter 2 inhibitors, *GLUCOSE, *OXIDANT status, *DIABETIC nephropathies

المؤلفون: Chen, Sha¹ (AUTHOR) s.chen1@amsterdamumc.nl, Wang, Qian¹ (AUTHOR) q.w.wang@amsterdamumc.nl, Christodoulou, Andriana² (AUTHOR) andrichristod@hotmail.com, Mylonas, Nikolaos² (AUTHOR) mylonasn@hotmail.com, Bakker, Diane¹ (AUTHOR) diane.bakker@amsterdamumc.nl, Nederlof, Rianne³ (AUTHOR) Rianne.Nederlof@uni-duesseldorf.de, Hollmann, Markus W.¹ (AUTHOR) m.w.hollmann@amsterdamumc.nl, Weber, Nina C.¹ (AUTHOR) n.c.hauck@amsterdamumc.nl, Coronel, Ruben⁴ (AUTHOR) rubencoronel@gmail.com, Wakker, Vincent⁵ (AUTHOR) famwakker@hotmail.com, Christoffels, Vincent M.⁵ (AUTHOR) v.m.christoffels@amsterdamumc.nl, Andreadou, Ioanna² (AUTHOR) jandread@pharm.uoa.gr, Zuurbier, Coert J.¹ (AUTHOR) c.j.zuurbier@amsterdamumc.nl

المصدر: Circulation. 1/17/2023, Vol. 147 Issue 3, p276-279. 4p.

مصطلحات موضوعية: *EMPAGLIFLOZIN, *GLUCOSE, *SODIUM-glucose cotransporter 2 inhibitors, *SODIUM

المصدر: Clinical & Experimental Pharmacology & Physiology. Jun2022, Vol. 49 Issue 6, p699-699. 1p.

مصطلحات موضوعية: *SODIUM-glucose cotransporters, *SODIUM-glucose cotransporter 2 inhibitors, *HYPOGLYCEMIA, *IPRAGLIFLOZIN, *GLUCOSE, *EXCRETION, *INSULIN aspart, *INSULIN